Synthesis presents how systemic drivers affect podocytes, indicating the need for dual therapeutic methods.
Summary I synthesize how systemic drivers (hypertension, diabetes, renin-angiotensin-aldosterone system activation) elevate glomerular capillary hydrostatic pressure and cyclic strain and how podocytes sense and respond to these loads via integrins, the slit diaphragm, and stretch-activated ion channels. When podocytes' normal adaptation mechanisms are overwhelmed by higher loads, inflammatory priming, genetic risk, or loss of cytoskeletal resilience, podocytes retract, detach, and are not meaningfully replaced, driving progressive glomerulosclerosis. Therapeutically, benefit follows two complementary strategies: lowering glomerular capillary hydrostatic pressure (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, sodium-glucose cotransporter 2 inhibitors, endothelin antagonism) and reinforcing podocyte mechanoadaptation (stabilizing actin/adhesion, modulating Ca²⁺ signaling, targeting load-sensing nodes). Taken together, progressive glomerulosclerosis is best explained by a model in which elevated single-nephron pressure loads exceed podocyte mechanoadaptive capacity. Durable protection will therefore require concurrent control of intraglomerular pressure and podocyte mechanotransduction. Semin Nephrol 36:x-xx © 20XX Elsevier Inc. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Kang Zhang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: